Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- hBD2's chemotactic effect and receptor
- DCs' activating effect of beta-defensin-2
- Alarmins recruit and activate APC
- Definition of DAMPs
- Antimicrobial proteins act as alarmins
- Mechanism of action of alarmins: granulysin
- Granulysin activates DCs by TLR4
- Anti-granulysin blocks the DC-activating effect
- NK92 supernatant activates DCs by TLR4
- No endotoxin contamination in granulysin effect
- Alarming effects of granulysin
- Why study HMGN1?
- HMGN1 induction of DC recruitment
- HMGN1 induces phenotypic maturation of DCs
- HMGN1 induces functional maturation of DCs
- HMGN1 promotes Th1-OVA immune response
- HMGN1 acts like a cytokine
- HMGN1 induced multiple signaling pathways
- DCs activation was MyD88 and TRIF -dependent
- HMGN1 activation of DCs was TLR4 -dependent
- HMGN1 expressed in insect cells was active
- Synthetic peptide of HMGN1 activates DCs
- HMGN1 interacts with MD2
- HMGN1 behaves like a non-leukocytic cytokine
- Hmgn1 KO mice can't produce cytokines
- Hmgn1 KO mice have deficient immune response
- How Hmgn1 promotes immune responses (1)
- How Hmgn1 promotes immune responses (2)
- KO mice show reduced leukocytes recruitment
- HMGN1 derived from non-leukocytes
- EG7 tumor grew rapidly in Hmgn1 KO mice
- HMGN1-induced DC signaling and activation
- HMGN1 is a key alarmin
- Alarmin-TAA fusion induces anti-tumor immunity
- Potent Th1/Th2 polarizing alarmins
- Alarmin-like/DAMP's
- Acknowledgements
Topics Covered
- Definition of Alarmins and Damps
- History of discovery that antimicrobial peptides such as Beta Defensins recruit and activate immune cells engaged in host defense
- Identification of other antimicrobials such as granulysin and nuclear binding factors, e.g. HMGN1, as also acting as alarmins that activate receptors on host cells
- Proposal to use some alarmins as vaccine adjuvants
Talk Citation
Oppenheim, J.J. (2011, December 5). Receptor identification for alarmins and DAMPs [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/NZYK4018.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Joost J. Oppenheim has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.